MAZE
MAZE clinical trials: Maze Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Maze Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MAZE on the catalyst calendar · MAZE registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 2027Sponsor estimate | NCT07694440A Study of MZE782 in Adults With PKUMaze Therapeutics · Phenylketonuria (PKU) | MAZELead | Phase 2 | Recruiting | Locked | Locked | Locked |
| Sep 2026Sponsor estimate | NCT06830629A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseMaze Therapeutics · Proteinuric Kidney Disease | MAZELead | Phase 2 | Recruiting | Locked | Locked | Locked |
| Dec 21, 2022Actual | NCT05249621A Randomized Phase 1 of of MZE001 in Healthy VolunteersMaze Therapeutics · Healthy | MAZELead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Dec 2027Sponsor estimatePhase 2NCT07694440A Study of MZE782 in Adults With PKUMaze Therapeutics · Phenylketonuria (PKU)RecruitingMAZELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2026Sponsor estimatePhase 2NCT06830629A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseMaze Therapeutics · Proteinuric Kidney DiseaseRecruitingMAZELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 21, 2022ActualPhase 1NCT05249621A Randomized Phase 1 of of MZE001 in Healthy VolunteersMaze Therapeutics · HealthyCompletedMAZELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner